On June 1, 2026, GSK plc reported the purchase of 1,249,269 shares between May 26-29, 2026 as part of its buyback program, bringing total treasury shares to 265,968,706. The buyback reflects a continued strategy to manage shareholder interests with shares bought at prices averaging around 1,920 pence each.